Ligand density vs mechanistic insight: a ligand conjugated formulation for the treatment of triple-negative breast cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Click Chemistry and Applications · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Alkilany AM, Zhu L, Weller H, Mews A, Parak WJ, Barz M, Feliu N (2019) Ligand density on nanoparticles: a parameter with critical impact on nanomedicine. Adv Drug Deliv Rev 143:22–36. https://doi.org/10.1016/j.addr.2019.05.01010.1016/j.addr.2019.05.010 ↗
2. Angelopoulou A, Kolokithas-Ntoukas A, Fytas C, Avgoustakis K (2019) Folic acid-functionalized, condensed magnetic nanoparticles for targeted delivery of doxorubicin to tumor cancer cells overexpressing the folate receptor. ACS Omega 4(26):22214–22227. https://doi.org/10.1021/ACSOMEGA.9B03594. (/ASSET/IMAGES/MEDIUM/AO9B03594_M002.GIF)10.1021/ACSOMEGA.9B03594 ↗
3. Bakshi AK, Haider T, Tiwari R, Soni V (2022) Critical parameters for design and development of multivalent nanoconstructs: recent trends. Drug Deliv Transl Res 12(10):2335–2358. https://doi.org/10.1007/S13346-021-01103-410.1007/S13346-021-01103-4 ↗
4. Cheng C-Y, Ou K-L, Huang W-T, Chen J-K, Chang J-Y, Yang C-H (2013) Gadolinium-based CuInS2/ZnS nanoprobe for dual-modality magnetic resonance/optical imaging. ACS Publications 5(10):4389–4400. https://doi.org/10.1021/am401428n10.1021/am401428n ↗
5. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A (2012) Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338(6109):903–910. https://doi.org/10.1126/science.122633810.1126/science.1226338 ↗
6. Fernández M, Javaid F, Chudasama V (2018) Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem Sci 9(4):790–790. https://doi.org/10.1039/C7SC04004K10.1039/C7SC04004K ↗
7. Filgueiras MdC, Morrot A, Soares PMG, Costa ML, Mermelstein C (2013) Effects of 5-fluorouracil in nuclear and cellular morphology, proliferation, cell cycle, apoptosis, cytoskeletal and caveolar distribution in primary cultures of smooth muscle cells. PLoS ONE 8(4):e63177–e63177. https://doi.org/10.1371/JOURNAL.PONE.006317710.1371/JOURNAL.PONE.0063177 ↗
8. Gholibegloo E, Mortezazadeh T, Salehian F, Forootanfar H, Firoozpour L, Foroumadi A, Ramazani A, Khoobi M (2019) Folic acid decorated magnetic nanosponge: an efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging. J Colloid Interface Sci 556:128–139. https://doi.org/10.1016/J.JCIS.2019.08.04610.1016/J.JCIS.2019.08.046 ↗
9. Hada AM, Craciun AM, Focsan M, Borlan R, Soritau O, Todea M, Astilean S (2021) Folic acid functionalized gold nanoclusters for enabling targeted fluorescence imaging of human ovarian cancer cells. Talanta 225:121960–121960. https://doi.org/10.1016/J.TALANTA.2020.12196010.1016/J.TALANTA.2020.121960 ↗
10. He S, Liu Z, Oh DY, Thiele CJ (2013) MYCN and the epigenome. Frontiers in Oncology. https://doi.org/10.3389/FONC.2013.00001/FULL10.3389/FONC.2013.00001/FULL ↗
11. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Banaszak Holl MM (2007) The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14(1):107–115. https://doi.org/10.1016/J.CHEMBIOL.2006.11.01510.1016/J.CHEMBIOL.2006.11.015 ↗
12. Kim SL, Jeong HJ, Kim EM, Lee CM, Kwon TH, Sohn MH (2007) Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies. J Korean Med Sci 22(3):405–405. https://doi.org/10.3346/JKMS.2007.22.3.40510.3346/JKMS.2007.22.3.405 ↗
13. Leamon CP, Vlahov IR, Reddy JA, Vetzel M, Krishna H, Santhapuram R, You F, Bloomfield A, Dorton R, Nelson M, Kleindl P, Vaughn JF, Westrick E (2014) Folate–vinca alkaloid conjugates for cancer therapy: a structure–activity relationship. ACS Publications 25(3):560–568. https://doi.org/10.1021/bc400441s10.1021/bc400441s ↗
14. Li Y, Wang S, Song FX, Zhang L, Yang W, Wang HX, Chen QL (2020) A pH-sensitive drug delivery system based on folic acid-targeted HBP-modified mesoporous silica nanoparticles for cancer therapy. Colloids Surf A Physicochem Eng Asp 590:124470–124470. https://doi.org/10.1016/J.COLSURFA.2020.12447010.1016/J.COLSURFA.2020.124470 ↗
15. Low PS, WAHA o.c., & undefined (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. ACS Publications 41(1):120–129. https://doi.org/10.1021/ar700081510.1021/ar7000815 ↗
16. Ly JD, Grubb DR, Lawen A (2003) The mitochondrial membrane potential (δψm) in apoptosis; an update. Apoptosis 8(2):115–128. https://doi.org/10.1023/A:1022945107762. (METRICS)10.1023/A:1022945107762 ↗
17. Mariadoss AVA, Saravanakumar K, Sathiyaseelan A, Venkatachalam K, Wang MH (2020) Folic acid functionalized starch encapsulated green synthesized copper oxide nanoparticles for targeted drug delivery in breast cancer therapy. Int J Biol Macromol 164:2073–2084. https://doi.org/10.1016/J.IJBIOMAC.2020.08.03610.1016/J.IJBIOMAC.2020.08.036 ↗
18. Mattos ACD, Altmeyer C, Tominaga TT, Khalil NM, Mainardes RM (2016) Polymeric nanoparticles for oral delivery of 5-fluorouracil: formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study. Eur J Pharm Sci 84:83–91. https://doi.org/10.1016/J.EJPS.2016.01.01210.1016/J.EJPS.2016.01.012 ↗
19. Moradi E, Vllasaliu D, Garnett M, Falcone F, Stolnik S (2012) Ligand density and clustering effects on endocytosis of folate modified nanoparticles. RSC Adv 2(7):3025–3033. https://doi.org/10.1039/C2RA01168A10.1039/C2RA01168A ↗
20. Narmani A, Rezvani M, Farhood B, Darkhor P, Mohammadnejad J, Amini B, Refahi S, Abdi Goushbolagh N (2019) Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug Dev Res 80(4):404–424. https://doi.org/10.1002/DDR.2154510.1002/DDR.21545 ↗
21. Panwar D, Thakor P, Sharma M, Bakshi AK, Bhavana V, Srivastava V, Mishra PR, Singh SB, Mehra NK (2023) Hyaluronic acid-engineered Bcl-2 inhibitor nanocrystals for site-specific delivery to breast tumor cells. Nanomedicine (Lond) 18(15):1005–1023. https://doi.org/10.2217/NNM-2023-013210.2217/NNM-2023-0132 ↗
22. Patel NR, Piroyan A, Nack AH, Galati CA, McHugh M, Orosz S, Keeler AW, O’Neal S, Zamboni WC, Davis B, Coleman TP (2016) Design, synthesis, and characterization of folate-targeted platinum-loaded theranostic nanoemulsions for therapy and imaging of ovarian cancer. ACS Publications 13(6):40–40. https://doi.org/10.1021/acs.molpharmaceut.6b0014910.1021/acs.molpharmaceut.6b00149 ↗
23. Pinedo HM, Peters GFJ (2016) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6(10):1653–1664. https://doi.org/10.1200/JCO.1988.6.10.165310.1200/JCO.1988.6.10.1653 ↗
24. Poon Z, Chen S, Engler AC, Lee HI, Atas E, Von Maltzahn G, Bhatia SN, Hammond PT (2010) Ligand-clustered “patchy” nanoparticles for modulated cellular uptake and in vivo tumor targeting. Angew Chem Int Ed Engl 49(40):7266–7270. https://doi.org/10.1002/ANIE.20100344510.1002/ANIE.201003445 ↗
25. Ramezani Farani M, Azarian M, Heydari Sheikh Hossein H, Abdolvahabi Z, Mohammadi Abgarmi Z, Moradi A, Mousavi SM, Ashrafizadeh M, Makvandi P, Saeb MR, Rabiee N (2022) Folic acid-adorned curcumin-loaded iron oxide nanoparticles for cervical cancer. ACS Appl Bio Mater 5(3):1305–1305. https://doi.org/10.1021/ACSABM.1C0131110.1021/ACSABM.1C01311 ↗
26. Sharma M, Bakshi AK, Mittapelly N, Gautam S, Marwaha D, Rai N, Singh N, Tiwari P, Agarwal N, Kumar A, Mishra PR (2022) Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. Journal of controlled release : official journal of the Controlled Release Society 346:43–70. https://doi.org/10.1016/J.JCONREL.2022.04.00710.1016/J.JCONREL.2022.04.007 ↗
27. Sharma M, Mittapelly N, Banala VT, Urandur S, Gautam S, Marwaha D, Rai N, Singh N, Gupta A, Mitra K, Mishra PR (2022) Amalgamated microneedle array bearing ribociclib-loaded transfersomes eradicates breast cancer via CD44 targeting. Biomacromol 23(3):661–675. https://doi.org/10.1021/ACS.BIOMAC.1C0107610.1021/ACS.BIOMAC.1C01076 ↗
28. Shukla RP, Urandur S, Banala VT, Marwaha D, Gautam S, Rai N, Singh N, Tiwari P, Shukla P, Mishra PR (2021) Development of putrescine anchored nano-crystalsomes bearing doxorubicin and oleanolic acid: deciphering their role in inhibiting metastatic breast cancer. Biomater Sci 9(5):1779–1794. https://doi.org/10.1039/D0BM01033B10.1039/D0BM01033B ↗
29. Simons K, Fuller SD (1985) Cell surface polarity in epithelia. Annu Rev Cell Biol 1:243–288. https://doi.org/10.1146/annurev.cb.01.110185.00133110.1146/annurev.cb.01.110185.001331 ↗
30. Siwowska K, Haller S, Bortoli F, Benešová M, Groehn V, Bernhardt P, Schibli R, Müller C (2017) Preclinical comparison of albumin-binding radiofolates: impact of linker entities on the in vitro and in vivo properties. Mol Pharm 14(2):523–532. https://doi.org/10.1021/ACS.MOLPHARMACEUT.6B0101010.1021/ACS.MOLPHARMACEUT.6B01010 ↗
31. Smith AM, Marbella LE, Johnston KA, Hartmann MJ, Crawford SE, Kozycz LM, Seferos DS, Millstone JE (2015) Quantitative analysis of thiolated ligand exchange on gold nanoparticles monitored by 1H NMR spectroscopy. Anal Chem 87(5):2771–2778. https://doi.org/10.1021/ac504081k10.1021/ac504081k ↗
32. Sokal RR, Rohlf FJ (1995) biometry: the principles and practice of statistics in biological research. San Francisco: W-. H. Freeman and Company. https://scholar.google.com/scholar_lookup?title=Drug+Delivery:+Principles+and+Applications&author=C.+V.+Galliford&author=P.+S.+Low&publication_year=2016
33. Srinivasarao M, Galliford CV, Low PS (2015) Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat Rev Drug Discov 14(3):203–219. https://doi.org/10.1038/nrd451910.1038/nrd4519 ↗
34. Stella B, Arpicco S, Peracchia MT et al (2010) Design of folic acid‐conjugated nanoparticles for drug targeting. Elsevier. https://doi.org/10.2147/CMR.S1004310.2147/CMR.S10043 ↗
35. Tagde P, Kulkarni GT, Mishra DK, Kesharwani P (2020) Recent advances in folic acid engineered nanocarriers for treatment of breast cancer. J Drug Deliv Sci Technol 56:101613–101613. https://doi.org/10.1016/J.JDDST.2020.10161310.1016/J.JDDST.2020.101613 ↗
36. Tang Z, Li D, Sun H, Guo X, Chen Y, Zhou S (2014) Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density. Biomaterials 35(27):8015–8027. https://doi.org/10.1016/J.BIOMATERIALS.2014.05.09110.1016/J.BIOMATERIALS.2014.05.091 ↗
37. Tiwari P, Yadav K, Shukla RP, Gautam S, Marwaha D, Sharma M, Mishra PR (2023) Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy. J Control Release 363:290–348. https://doi.org/10.1016/J.JCONREL.2023.09.01610.1016/J.JCONREL.2023.09.016 ↗
38. Ullah S, Azad AK, Nawaz A, Shah KU, Iqbal M, Albadrani GM, Al-Joufi FA, Sayed AA, Abdel-Daim MM (2022) 5-fluorouracil-loaded folic-acid-fabricated chitosan nanoparticles for site-targeted drug delivery cargo. Polymers. https://doi.org/10.3390/POLYM1410201010.3390/POLYM14102010 ↗
39. White KA, Grillo-Hill BK, Barber DL (2017) Cancer cell behaviors mediated by dysregulated pH dynamics at a glance. J Cell Sci 130(4):663–663. https://doi.org/10.1242/JCS.19529710.1242/JCS.195297 ↗
40. Yang C, Gao S, Kjems J (2014) Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo. J Mater Chem B 2(48):8608–8615. https://doi.org/10.1039/C4TB01374C10.1039/C4TB01374C ↗
41. Zhu Y, Hou J, Gray DM, McDonald TO, Dumanli AG (2024) Cation-induced morphological transitions and aggregation of thermoresponsive PNIPAM nanogels. Heliyon 10(12):e3218410.1016/j.heliyon.2024.e32184 ↗